ATP-responsive nanoparticles for improved chemodynamic therapy and dual starvation therapy
Cancer has become a serious threat to human health and the search for a safe and effective treatment method is particularly urgent. Chemodynamic therapy (CDT) is a non-invasive therapeutic method, but CDT still has certain disadvantages such as its limited therapeutic efficacy through overexpression of GSH and single treatment mode. In this paper, ZIF-based nanoparticles called Cu<sup>2+</sup>-SK-GOD@ZIF-90 are constructed for improved chemodynamic therapy and dual starvation therapy (ST). The nanoparticles are destroyed by high levels of ATP in cancer cells, releasing Cu<sup>2+</sup>, shikonin (SK) and glucose oxidase (GOD). Under the action of Cu<sup>2+</sup> and GSH, Cu<sup>+</sup> is generated and catalyzes H<sub>2</sub>O<sub>2</sub> to produce ˙OH for CDT by a Fenton-like reaction. Both the depletion of GSH and the production of H<sub>2</sub>O<sub>2</sub> improve the effect of chemodynamic therapy. Moreover, SK and GOD are used for dual starvation therapy by inhibiting glycolysis and blocking glucose, respectively. <i>In vivo</i> experiments have demonstrated that the synergistic combination of CDT and dual ST via treatment with Cu<sup>2+</sup>-SK-GOD@ZIF-90 can effectively inhibit the growth of tumors and significantly prolong the survival of mice, and is superior to treatment with Cu<sup>2+</sup>@ZIF-90 and Cu<sup>2+</sup>-SK@ZIF-90. This synergistic treatment combining CDT and ST offers an effective and safe way to treat cancer.
Authors
- Guojiang Mao (ORCID: https://orcid.org/0000-0001-9406-8206)
- Jun Long (ORCID: https://orcid.org/0009-0008-6097-0646)
- Juan Ouyang (ORCID: https://orcid.org/0009-0000-1586-845X)
- Zhiqiang Wang (ORCID: https://orcid.org/0000-0002-5839-743X)
- Chunyan Li (ORCID: https://orcid.org/0000-0002-8382-5264)
- Yongfei Li (ORCID: https://orcid.org/0000-0002-7206-2564)
- Juntao Chen (ORCID: https://orcid.org/0000-0001-8421-8821)
- Xiao-Fan Xu
- Qian Song
- Liufang Hu
Institutions
- Xiangtan University (CN)
- Henan Normal University (CN)
Publication Details
- Journal
- Nanoscale
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5nr02053k
- Citations
- 2
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Henan Normal University
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Natural Science Foundation of Guangdong Province
- Natural Science Foundation of Hunan Province